drugset / Trial / NCT01106066

Phase I/II Study of Neoadjuvant Chemoradiotherapy With S-1/ Oxaliplatin in Patients With Gastric Cancer: Randomized Phase II Study of S-1/RT vs. S-1/Oxaliplatin/RT

NCT01106066

Phase 1/2 Terminated 30 enrolled Samsung Medical Center
Non-randomizedSingle-groupOpen-labelTreatment

Summary

To evaluate the efficacy of preoperative S-1/oxaliplatin/RT in locally advanced gastric cancer

Timeline

Start
2009-03
Primary completion
2012-11
Completion
2012-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxaliplatin Small molecule Intravenous
Subject S-1 Small molecule Oral

Indications

No indication recorded.